Literature DB >> 18385143

In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study.

Andrew Walkty, Melanie Decorby, Kim Nichol, James A Karlowsky, Daryl J Hoban, George G Zhanel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18385143     DOI： 10.1093/jac/dkn140

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Ceftobiprole, a Broad-Spectrum Cephalosporin With Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Jamie Kisgen; Dana Whitney
Journal:  P T       Date:  2008-11

2.  Emerging agents to combat complicated and resistant infections: focus on ceftobiprole.

Authors:  César Bustos; Jose L Del Pozo
Journal:  Infect Drug Resist       Date:  2010-04-22       Impact factor: 4.003

3.  Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Roger Sordé; Albert Pahissa; Jordi Rello
Journal:  Infect Drug Resist       Date:  2011-01-25       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.